Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian F Pollack

Showing results (141-150 of 308) with videos related to

Pageof 31
Sort By:
Pediatric Blood & Cancer|July 5, 2007
Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factorsStergios Zacharoulis, Lingyun Ji, Ian F Pollack, et al.
Stereotactic and Functional Neurosurgery|March 19, 2005
The characterization of tumor apoptosis after experimental radiosurgeryTimothy F Witham, Hideho Okada, Wendy Fellows, et al.
Cancer|October 13, 2007
A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group studyMaryam Fouladi, H Stacy Nicholson, Tianni Zhou, et al.
Cancer|April 11, 2016
Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology GroupJoann L Ater, Caihong Xia, Claire M Mazewski, et al.
BMC Medical Genomics|January 29, 2011
A novel SNP analysis method to detect copy number alterations with an unbiased reference signal directly from tumor samplesAlex Lisovich, Uma R Chandran, Maureen A Lyons-Weiler, et al.
Pediatric Blood & Cancer|February 24, 2015
Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology GroupRegina I Jakacki, Peter C Burger, Mehmet Kocak, et al.
Neoplasia (New York, N.Y.)|October 7, 2005
EphA2 as a glioma-associated antigen: a novel target for glioma vaccinesManabu Hatano, Junichi Eguchi, Tomohide Tatsumi, et al.
Journal of Neurosurgery|March 3, 2007
Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohortIan F Pollack, Ronald L Hamilton, C David James, et al.
Neurosurgery|May 23, 2002
Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohortIan F Pollack, Ronald L Hamilton, Judith Burnham, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|November 6, 2010
DTI assessment of the brainstem white matter tracts in pediatric BSG before and after therapy: a report from the Pediatric Brain Tumor ConsortiumSanjay P Prabhu, Sarah Ng, Sridhar Vajapeyam, et al.
Pageof 31

Showing results (141-150 of 308) with videos related to

Sort By:
Pageof 31
Pediatric Blood & Cancer|July 5, 2007
Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factorsStergios Zacharoulis, Lingyun Ji, Ian F Pollack, et al.
Stereotactic and Functional Neurosurgery|March 19, 2005
The characterization of tumor apoptosis after experimental radiosurgeryTimothy F Witham, Hideho Okada, Wendy Fellows, et al.
Cancer|October 13, 2007
A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group studyMaryam Fouladi, H Stacy Nicholson, Tianni Zhou, et al.
Cancer|April 11, 2016
Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology GroupJoann L Ater, Caihong Xia, Claire M Mazewski, et al.
BMC Medical Genomics|January 29, 2011
A novel SNP analysis method to detect copy number alterations with an unbiased reference signal directly from tumor samplesAlex Lisovich, Uma R Chandran, Maureen A Lyons-Weiler, et al.
Pediatric Blood & Cancer|February 24, 2015
Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology GroupRegina I Jakacki, Peter C Burger, Mehmet Kocak, et al.
Neoplasia (New York, N.Y.)|October 7, 2005
EphA2 as a glioma-associated antigen: a novel target for glioma vaccinesManabu Hatano, Junichi Eguchi, Tomohide Tatsumi, et al.
Journal of Neurosurgery|March 3, 2007
Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohortIan F Pollack, Ronald L Hamilton, C David James, et al.
Neurosurgery|May 23, 2002
Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohortIan F Pollack, Ronald L Hamilton, Judith Burnham, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|November 6, 2010
DTI assessment of the brainstem white matter tracts in pediatric BSG before and after therapy: a report from the Pediatric Brain Tumor ConsortiumSanjay P Prabhu, Sarah Ng, Sridhar Vajapeyam, et al.
Pageof 31